Blood pressure and cardiovascular risk in the HOPE study

Lancet. 2002 Jun 15;359(9323):2117-8; author reply 2118. doi: 10.1016/S0140-6736(02)98967-1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Blood Pressure / drug effects*
  • Cardiovascular Diseases / prevention & control*
  • Confounding Factors, Epidemiologic
  • Female
  • Humans
  • Male
  • Ramipril / therapeutic use*
  • Randomized Controlled Trials as Topic / methods*
  • Risk Factors

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Ramipril